Pacira BioSciences Cash Flow Statement (2010-2026) | PCRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	19.08M	17.66M	-5.13M	6.83M	19.88M	-0.69M	-10.10M	-19.54M	25.76M	10.86M	24.87M	8.98M	18.89M	-143.47M	16.04M	4.81M	-4.85M	5.43M	1.64M	2.92M
Depreciation and Depletion (Quarter)	2.90M	3.80M	5.40M	5.70M	6.50M	5.80M	16.20M	5.30M	4.70M	4.10M	4.20M	4.10M	4.50M	6.00M	6.90M	6.80M	13.00M	6.90M	7.00M	7.00M
Share-based Compensation (Quarter)	10.46M	10.78M	10.89M	11.19M	11.54M	12.68M	12.68M	11.99M	10.96M	12.53M	12.42M	13.15M	12.52M	13.23M	12.27M	14.55M	15.47M	13.98M	13.50M	13.54M
Deferred Taxes (Quarter)	5.87M	5.34M	-2.08M	0.03M	2.16M	0.70M	-10.84M	-7.34M	11.44M	4.91M	6.60M	3.46M	12.54M	1.11M	3.51M	1.40M	0.75M	8.07M	-3.74M	1.73M
Gains from Investment Securities (Quarter)	0.14M		1.20M	-0.01M	12.52M	0.50M	9.62M	0.20M	-18.30M	2.80M	5.98M	-3.81M	1.51M	-3.24M	-0.18M	-2.70M	-0.36M	0.60M	0.14M	4.36M
Asset Writedowns and Impairment (Quarter)							16.13M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	30.13M	60.29M	23.21M	30.78M	29.81M	42.65M	42.04M	19.13M	43.50M	44.44M	47.58M	49.10M	53.24M	53.92M	33.13M	35.46M	12.01M	60.83M	43.69M	25.68M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)														163.20M
Amortizatization of Intangibles (Quarter)	5.74M	5.84M	5.91M	0.71M	0.71M	0.69M	0.70M	0.68M	0.03M	0.03M	3.85M	0.02M	0.02M	0.02M	7.35M	1.91M	0.02M	0.06M	4.83M	0.57M
Amortization of Deferred Charges (Quarter)								0.94M	0.69M	0.68M	1.44M	0.68M	0.76M	0.84M	0.94M	0.84M	0.85M	0.63M	0.68M	0.58M
Depreciation & Amortization (CF) (Quarter)	4.90M	5.73M	13.07M	20.03M	20.86M	20.20M	30.41M	19.60M	19.05M	18.43M	18.48M	18.43M	18.86M	20.25M	21.24M	21.17M	27.32M	21.19M	21.34M	21.33M
Change in Working Capital
Change in Receivables (Quarter)	15.77M	-18.38M	13.50M	-4.21M	-1.00M	2.37M	4.93M	-5.19M	5.88M	-2.12M	8.60M	-3.92M	3.14M	-4.13M	12.65M	-8.56M	9.61M	0.90M	8.80M	1.57M
Change in Inventory (Quarter)	0.66M	1.95M	1.91M	5.11M	-3.07M	-3.79M	-0.73M	-3.09M	-0.85M	4.39M	7.83M	-7.57M	6.66M	8.43M	13.42M	8.47M	14.40M	9.51M	-4.82M	-2.49M
Change in Account Payables (Quarter)	3.51M	-2.98M	-9.44M	6.11M	-0.85M	-0.58M	1.59M	2.63M	7.05M	-7.70M	-1.07M	-6.98M	9.75M	0.64M	-0.33M	2.46M	6.88M	-12.01M	-2.93M	-0.94M
Change in Accured Expenses (Quarter)	-0.11M	1.11M	16.93M	-9.16M	9.64M	-24.04M	3.70M	0.42M	-0.14M	-0.24M	-21.64M	-0.77M	2.13M	-2.56M	15.63M	4.70M	6.20M	-5.83M	1.77M	3.29M
Other Working Capital Changes (Quarter)	1.20M	-1.85M	-0.23M	4.26M	-1.03M	-2.67M	2.13M	1.93M	2.44M	2.62M	-1.92M	-0.90M	2.21M	5.03M	-6.40M	5.20M	13.43M	-4.72M	-12.70M	4.54M
Investing Activities
Capital Expenditures (Quarter)	-4.98M	28.60M	-29.87M	7.67M	11.73M	5.18M	5.49M	6.57M	3.40M	-8.50M	13.69M	2.84M	-2.23M	-0.19M	10.22M	8.55M	2.70M	3.87M	-13.65M	1.36M
Acquisitions (Quarter)																16.70M				0.34M
Change in Acquisitions & Divestments (Quarter)	149.01M	176.33M	598.12M		62.94M	89.70M	84.94M	126.25M	33.50M	41.23M	36.10M	43.36M	36.10M	53.16M	46.95M	69.25M	71.17M	86.25M	47.14M	22.50M
Cash from Investing Activities (Quarter)	3.03M	-35.08M	66.92M	-208.02M	19.16M	-47.52M	11.19M	66.18M	7.33M	-4.34M	8.37M	-15.53M	-15.21M	-52.16M	-0.37M	-25.63M	62.16M	43.61M	19.33M	19.44M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	5.91M	3.05M	361.41M	-181.59M	-153.66M	-7.78M	-58.51M	-153.91M	0.44M	-27.79M	-1.78M	-2.82M	24.98M	-2.85M	-1.96M	-2.99M	-57.51M	-257.48M	-51.65M	-59.40M
Additional items
Exchange Rate Effect (Quarter)																	0.20M	0.13M	-0.41M	0.04M
Change in Cash (Quarter)	39.08M	28.26M	451.54M	-358.83M	-104.69M	-12.64M	-5.29M	-68.59M	51.27M	12.31M	54.18M	30.75M	63.00M	-1.09M	30.81M	6.84M	16.87M	-152.90M	10.96M	-14.24M
Free Cash Flow (Quarter)	35.11M	31.68M	53.09M	23.11M	18.07M	37.47M	36.55M	12.56M	40.09M	52.94M	33.89M	46.27M	55.47M	54.11M	22.91M	26.91M	9.31M	56.96M	57.34M	24.32M
Net Cash Flow (Quarter)	39.08M	28.26M	451.54M	-358.83M	-104.69M	-12.64M	-5.29M	-68.59M	51.27M	12.31M	54.18M	30.75M	63.00M	-1.09M	30.81M	6.84M	16.67M	-153.03M	11.37M	-14.28M

Research Tools

Pacira BioSciences Cash Flow Statement (2010-2026) | PCRX

Create an account

Sign In

Reset Password